SELECT FROM MENU

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

2025 Approvals & Highlights

2025 Approvals & Highlights

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in 2025 Highlights in Lung Cancer Martin Reck Germany Solange Peters Switzerland Agenda & Discussion Topics Current Standards...
Small Cell Lung Cancer

Small Cell Lung Cancer

Small Cell Lung Cancer THE EMERGING ROLE OF DLL3 T-CELL ENGAGERS IN SCLC Giannis Mountzios EXPANDING OUR OPTIONS WITH IO COMBINATION THERAPIES IN LS- AND ES-SCLC Jacob Sands Open Discussion, Viewer Questions & Patient Cases Solange Peters  17 June 2025 } 1 h 35...

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates